| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA2321372 | B | Selectivity ratio of IC50 for human COX2 to IC50 for human mPGES-1 | Homo sapiens | 1 | ALA2311506 | assay format | Scientific Literature | |
| 2. | ALA2321373 | B | Selectivity ratio of IC50 for 6-keto PGF1alpha (unknown origin) to IC50 for human mPGES-1 | Homo sapiens | 1 | ALA2311506 | assay format | Scientific Literature | |
| 3. | ALA2321377 | A | Half life in human hepatocytes | Homo sapiens | 1 | ALA2311506 | cell-based format | Scientific Literature | |
| 4. | ALA2321378 | B | Inhibition of COX2 in dog whole blood assessed as LPS-induced PGE2 production | Canis lupus familiaris | 1 | ALA2311506 | single protein format | Scientific Literature | |
| 5. | ALA2321379 | B | Inhibition of recombinant rat mPGES-1 using PGH2 as substrate incubated 20 mins prior to substrate addition measured after 30 secs by EIA | Rattus norvegicus | 1 | ALA2311506 | assay format | Scientific Literature | |
| 6. | ALA2321380 | B | Inhibition of COX2 in rat synovial fibroblast assessed as inhibition of IL-1-mediated PGE2 production | Rattus norvegicus | 1 | ALA2311506 | assay format | Scientific Literature | |
| 7. | ALA2321381 | B | Inhibition of COX2 in human whole blood assessed as LPS-induced PGE2 production incubated 15 mins prior to LPS challenge measured after 24 hrs by EIA | Homo sapiens | 1 | ALA2311506 | single protein format | Scientific Literature | |
| 8. | ALA2321382 | B | Inhibition of COX2 in human fetal fibroblast assessed as SnCl2-induced PGF2alpha production after 40 mins by ELISA | Homo sapiens | 2 | ALA2311506 | single protein format | Scientific Literature | |
| 9. | ALA2321383 | B | Inhibition of human PGDS | Homo sapiens | 1 | ALA2311506 | single protein format | Scientific Literature | |
| 10. | ALA2321384 | A | Tmax in dog at 0.5 mg/kg, po | Canis lupus familiaris | 1 | ALA2311506 | organism-based format | Scientific Literature | |
| 11. | ALA2321385 | A | Oral bioavailability in dog at 0.5 | Canis lupus familiaris | 1 | ALA2311506 | organism-based format | Scientific Literature | |
| 12. | ALA2321386 | A | Half life in dog at 0.25 mg/kg, iv | Canis lupus familiaris | 1 | ALA2311506 | organism-based format | Scientific Literature | |
| 13. | ALA2321387 | A | Cmax in dog at 0.5 mg/kg, po | Canis lupus familiaris | 1 | ALA2311506 | organism-based format | Scientific Literature | |
| 14. | ALA2321388 | A | Volume of distribution at steady state in dog at 0.25 mg/kg, iv | Canis lupus familiaris | 1 | ALA2311506 | organism-based format | Scientific Literature | |
| 15. | ALA2321389 | A | Clearance in dog at 0.25 mg/kg, iv | Canis lupus familiaris | 1 | ALA2311506 | organism-based format | Scientific Literature | |
| 16. | ALA2321390 | A | Mean residence time in dog at 0.25 mg/kg, iv | Canis lupus familiaris | 1 | ALA2311506 | organism-based format | Scientific Literature | |
| 17. | ALA2321391 | A | Plasma protein binding in rat | Rattus norvegicus | 1 | ALA2311506 | cell-free format | Scientific Literature | |
| 18. | ALA2321392 | A | Half life in human liver microsomes | Homo sapiens | 1 | ALA2311506 | microsome format | Scientific Literature | |
| 19. | ALA2321393 | A | Half life in rat liver microsomes | Rattus norvegicus | 1 | ALA2311506 | microsome format | Scientific Literature | |
| 20. | ALA2321394 | A | Permeability of the compound by pampa | 1 | ALA2311506 | assay format | Scientific Literature |
The page will load shortly, Thanks for your patience!